BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

9667

540937

MEDICO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDICO REMEDIES LIMITED performance

Today’s low

Today’s high

₹ 54.59 ₹ 58.00
₹ 55.66

52 week low

52 week high

₹ 34.80 ₹ 79.83
₹ 55.66

Open Price

₹ 56.95

Prev. Close

₹ 56.52

Volume (Shares)

210021.00

Total traded value

₹ 116.89

Upper Circuit

₹ 67.82

Lower Circuit

₹ 45.21

info

MEDICO REMEDIES LIMITED Share Price Update

As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at ₹ 55.66, which is down by ₹ -0.86 from its previous closing. Today, the stock has fluctuated between ₹ 54.59 and ₹ 58.00. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of 22.59 %. In the last month alone, the return has been 4.42 %. Read More...

MEDICO REMEDIES LIMITED fundamentals


  • Market cap (Cr)

    461.90

  • P/E Ratio (TTM)

    51.86

  • Beta

    0.35

  • Book Value / share

    6.68

  • Return on equity

    17.23%

  • EPS (TTM)

    1.07

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.62

info icon alternate text
  • Market cap (Cr)

    460.50

  • P/E Ratio (TTM)

    51.86

  • Beta

    0.34

  • Book Value / share

    6.68

  • Return on equity

    17.23%

  • EPS (TTM)

    1.07

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.62

info icon alternate text

MEDICO REMEDIES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 39.49
Operating Expense 37.42
Net Profit 2.62
Net Profit Margin (%) 6.63
Earnings Per Share (EPS) 0.32
EBITDA 4.54
Effective Tax Rate (%) 25.14
Particulars SEP 2024 (Values in Cr)
Revenue 39.35
Operating Expense 37.89
Net Profit 1.55
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.19
EBITDA 3.09
Effective Tax Rate (%) 27.23
Particulars JUN 2024 (Values in Cr)
Revenue 30.80
Operating Expense 28.91
Net Profit 1.58
Net Profit Margin (%) 5.12
Earnings Per Share (EPS) 0.19
EBITDA 3.11
Effective Tax Rate (%) 27.52
Particulars MAR 2024 (Values in Cr)
Revenue 41.32
Operating Expense 37.67
Net Profit 3.10
Net Profit Margin (%) 7.50
Earnings Per Share (EPS) 0.37
EBITDA 5.24
Effective Tax Rate (%) 27.05
Particulars DEC 2023 (Values in Cr)
Revenue 29.77
Operating Expense 27.98
Net Profit 1.45
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 0.17
EBITDA 3.00
Effective Tax Rate (%) 30.09
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2021 (Values in Cr)
Revenue 122.39
Operating Expense 119.73
Net Profit 2.59
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 6.25
EBITDA 6.26
Effective Tax Rate (%) 29.53
Particulars MAR 2020 (Values in Cr)
Revenue 88.64
Operating Expense 88.52
Net Profit 1.63
Net Profit Margin (%) 1.83
Earnings Per Share (EPS) 3.93
EBITDA 4.94
Effective Tax Rate (%) 26.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.31
ROE % 17.23
ROCE % 21.24
Total Debt to Total Equity 0.19
EBITDA Margin 10.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.98
ROE % 5.61
ROCE % 7.64
Total Debt to Total Equity 0.47
EBITDA Margin 5.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 96.19
Total Liabilities 96.19
Total Equity 52.37
Share Outstanding 82984000
Price to Book Ratio 7.81
Return on Assets (%) 8.61
Return on Capital (%) 14.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 82984000
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 16596800
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 4149200
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 75.26
Total Liabilities 75.26
Total Equity 29.86
Share Outstanding 4149200
Price to Book Ratio 1.02
Return on Assets (%) 2.16
Return on Capital (%) 3.91
Particulars MAR 2024 (Values in Cr)
Net Income 11.57
Cash from Operations 5.84
Cash from Investing -2.67
Cash from Financing -0.49
Net change in Cash -0.48
Free Cash Flow 5.84
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Particulars MAR 2020 (Values in Cr)
Net Income 2.21
Cash from Operations 1.54
Cash from Investing -3.08
Cash from Financing 2.59
Net change in Cash 0.48
Free Cash Flow 3.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

MEDICO REMEDIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
55.66 -1.52 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 56.80
  • 26 Days 56.70
  • 10 Days 57.00
  • 50 Days 57.40
  • 12 Days 57.00
  • 100 Days 57.30
  • 20 Days 56.70
  • 200 Days 56.50
56.84 PIVOT

First Support

55.68

First Resistance

57.67

Second Support

54.85

Second Resistance

58.83

Third Support

53.69

Third Resistance

59.66

RSI

47.60

ADX

6.40

MACD

0.30

Williams % R

-77.50

Commodity Channel Index (CCI)

-15.50

Date

2025-04-30

Week

265368.00

Same Day

127442.00

Month

302751.00

1 Year

0.35

3 Year

0.26

Over 1 Month

4.42%

down

Over 1 Year

22.59%

down

Over 3 Months

-25.20%

down

Over 3 Years

32.00%

down

Over 6 Months

-2.87%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MEDICO REMEDIES LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
36.07%
Promoter Holdings
63.79%
FII
0.11%
DII
0.01%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Haresh Kapurlal Mehta 1.72292E7 (20.76%) Shareholding of Promoter and Promoter Group
Rishit Hareshbhai Mehta 1.05E7 (12.65%) Shareholding of Promoter and Promoter Group
Harshit Haresh Mehta 9520000.0 (11.47%) Shareholding of Promoter and Promoter Group
Rita H Mehta 6828000.0 (8.23%) Shareholding of Promoter and Promoter Group
Ravi Goyal Huf 5678300.0 (6.84%) Public Shareholding
Shweta Harshit Mehta 5382170.0 (6.49%) Shareholding of Promoter and Promoter Group
Priyal Rishit Mehta 3477775.0 (4.19%) Shareholding of Promoter and Promoter Group
Harshit H Mehta Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Haresh K Mehta Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

MEDICO REMEDIES LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023

MEDICO REMEDIES LIMITED Share Price

Medico Remedies Limited was incorporated as a Private Limited Company with the name 'Medico Remedies Private Limited' on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017.

Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

The Company is ISO 9001:2015 certified for its management system for the manufacture and marketing of pharmaceutical products. It also obtained a WHO-GMP accreditation for the manufacture of its products from the World Health Organisation and has also been certified by Government Recognised Star Exports, Pharmacy and Poison Board, NAFDAC and National Drug Authority, Uganda.

The Company began its operations in 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 & 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and beta-lactam unit; the beta lactam unit is further divided into two segments -Penicillin and Cephalosporins.

The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.

In 2018-19, the Company purchased adjoining manufacturing unit with existing factory at Palghar.

In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.

Parent organization Indian Private
NSE symbol MEDICO
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Medico Remedies Ltd?

Answer Field

The share price of Medico Remedies Ltd for NSE is ₹ 55.66 and for BSE is ₹ 55.47.

What is the Market Cap of Medico Remedies Ltd?

Answer Field

The market cap of Medico Remedies Ltd for NSE is ₹ 4,61.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 79.83 and ₹ 34.80 and for BSE is ₹ 79.78 and ₹ 35.00.

How to Buy Medico Remedies Ltd share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 22.59%.

What is the Current Share Price of Medico Remedies Ltd?

Answer Field

Medico Remedies Ltd share price is for NSE ₹ 55.66 & for BSE ₹ 55.47 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Medico Remedies Ltd Share?

Answer Field

The market cap of Medico Remedies Ltd for NSE ₹ 4,61.90 & for BSE ₹ 0.0 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Medico Remedies Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 51.86.

What is the PB ratio of Medico Remedies Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 6.68.

How to Buy Medico Remedies Ltd Share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|